There are limited data on the concentrations of common contaminants Ð polychlorinated biphenyls (PCBs), dichlorodiphenyl dichloroethene (p,p H -DDE) and hexachlorobenzene (HCB) Ð in umbilical cord blood. Cord blood provides the primary direct measure of prenatal exposure to these contaminants, the key determinant of PCBs' neurodevelopmental toxicities. The objective of this study was to characterize cord blood levels of PCBs, p,p H -DDE, and HCB among 751 infants who were born between 1993 and 1998 to mothers residing adjacent to a PCB -contaminated harbor in New Bedford, Massachusetts, and for whom the neurodevelopmental toxicities of these compounds are being studied. We refined standard analytic methods to optimize the sensitivity and precision of trace -level PCB, p,p H -DDE, and HCB measurements in blood. Using these methods, we measured the concentrations of 51 individual PCBs, their sum ( P PCB), p,p H -DDE, and HCB in cord serum. With correction for background contamination, the respective mean SD cord serum concentrations of P PCB, p,p H -DDE, and HCB were 0.54 0.83, 0.48 0.94, and 0.03 0.04 ng / g serum. These concentrations were generally lower than those in most of the few published studies with congener -specific measures of PCBs in cord blood. However, for less -chlorinated PCB congeners (e.g., congeners 99 and 118), study samples had concentrations comparable to those in other populations, including groups at risk for high dietary PCB exposure. Of note, the contaminated harbor sediment has a relatively high proportion of less -chlorinated PCB congeners. Thus, although the P PCB in study infants was not higher than concentrations in infants studied elsewhere, the relative predominance of less -chlorinated congeners was generally consistent with the characteristics of the contaminated site.
Introduction
The production and use of polychlorinated biphenyls (PCBs) by the electronics and other manufacturing industries in the United States were banned in 1977 because of their toxicity, persistence in the environment, and bioaccumulation in human and animal tissue. Similarly, use of the insecticide dichlorodiphenyl trichloroethane (DDT), which is also persistent, bioaccumulating, and toxic, was banned in the United States in 1972 (Kutz et al., 1991) . Despite the longstanding ban on the use of PCBs and DDT, PCBs and dichlorodiphenyl dichloroethene (DDE, the most stable metabolite of DDT) are still ubiquitous contaminants in human blood. The chlorinated compound hexachlorobenzene (HCB) is also one of the most commonly found organochlorine contaminants of human serum. HCB is formed during incineration or as a byproduct in the manufacturing of pesticides, chlorinated solvents, and other chlorinated compounds. All of these chlorinated compounds Ð PCBs, DDT and DDE, and HCB Ð have wide -ranging potential toxicities including developmental toxicities that have been demonstrated in both animal models and human epidemiologic studies.
New Bedford harbor in southeastern Massachusetts is one of the most highly PCB -contaminated sites in the United States. PCBs were heavily used in New Bedford electronics manufacturing as electrical insulating compounds. Their disposal in the Acushnet River estuary and New Bedford harbor before 1977 resulted in substantial contamination of the river and harbor sediments with areas of up to 10% total PCBs by weight reported (Weaver, 1984) . The extreme PCB contamination of the harbor sediments has been a source of public health concern over the potential for PCB exposure and related health hazards among area residents. However, surveys of the New Bedford area adult population have not suggested excessive PCB exposure among residents, except in the subset of individuals with either heavy occupational or dietary (contaminated fish) sources of PCB exposure (Miller et al., 1991) .
The techniques used to measure serum PCB levels in the first population -based studies of PCB -associated developmental toxicities done in the 1970s and 1980s used packed column chromatography and quantification methods based on Aroclor (commercial PCB mixtures) formulations. Analytic chemistry advances implemented since then have resulted in the use of capillary column and congenerspecific analytic and quantification methods for PCB analyses. Congener-specific methods are more accurate for biological samples in which the PCB congener profile does not necessarily match the profile of commercial PCB formulations due to differences in bioaccumulation and metabolism of PCB congeners. In addition, congenerspecific analyses eliminate some of the limitations of older analytic approaches by taking into account differences (up to 50 -fold) in responsiveness of individual PCB congeners to electron capture detection (ECD) and by eliminating the use of commercial PCB mixtures as calibration standards because commercial PCB formulations do not have precisely standardized contents. Congener-specific analysis is especially useful in evaluating PCB toxicities because individual PCB congeners presumably have different toxicity as well as metabolism and excretion in mammalian systems. Measuring specific PCB congeners has the additional advantage of providing detailed information regarding the congener distribution within a serum sample that can be compared to congener patterns in other matrices (e.g., seafood). In theory, such comparisons can be used as a method to explore possible sources of PCB exposure (Luotamo, 1991) .
Limited data are available on the concentrations of PCBs, p,p H -DDE, and HCB in newborn umbilical cord blood. Cord blood analyses are complicated by the need to identify birth cohorts to retrieve specimens, the relatively low lipid content of the blood, and the resultant low concentrations of these lipophilic contaminants in the sample. For example, comparisons of paired mother ± infant serum samples are consistent with up to fivefold greater maternal than cord serum PCB levels for some congeners (Bush et al., 1984; Huisman et al., 1995) . Despite these limitations, cord blood offers the primary direct measure of prenatal exposure to these contaminants. Prenatal exposure, in turn, is believed to be the key determinant of PCBs' neurodevelopmental toxicities and is potentially critical to the hypothesized reproductive toxicities of PCBs and DDE. The objectives of this study were: (1) to document the analytic sensitivity, validity, and reproducibility of congener-specific PCB and organochlorine pesticide analyses in cord serum, and (2) to characterize cord serum levels of PCBs, p,p H -DDE, and HCB among a sample of New Bedford area infants for whom the neurodevelopmental toxicities of prenatal exposure to these compounds are being studied. Results of the neurodevelopmental assessments will be reported separately.
Methods

Study Population
Study participants were 788 infants born between March 1993 and December 1998 who were recruited at the time of birth from mothers at one of the main hospitals serving the greater New Bedford, Massachusetts area. Participation was limited to consenting adult mothers who had resided in the towns (New Bedford, Acushnet, Fairhaven, Dartmouth) bordering the New Bedford Harbor contaminated site for at least the duration of their pregnancy. Infants born by cesarean section or whose mothers were not conversant in English were excluded. Eligible infants were generally healthy; those requiring high -grade neonatal care were either transferred to other facilities or not able to undergo examination and thus were not available for study. In total, 762 (97%) of the infants had cord blood samples available for PCB and pesticide analyses. Eleven of these infants were excluded from the analysis because of laboratory problems with serum preparation or contamination, leaving 751 infants for these analyses, including two sets of twins and 28 sibling pairs. The study was approved by the Human Research Committees of Harvard School of Public Health and Brigham and Women's Hospital of Boston and St. Luke's Hospital of New Bedford. Consent was obtained from all study mothers before participation.
Cord Blood Collection
Cord blood samples were obtained in red top Vacutainer 2 tubes at each infant's birth, and the serum fraction was removed after being separated by centrifugation. The serum was stored in solvent -rinsed glass vials with Teflon 2 -lined caps at À 208C until extraction.
Laboratory Analysis
All sample analyses were performed by the Harvard School of Public Health Organic Chemistry Laboratory (Boston, Massachusetts).
Congener Analysis Cord serum samples were analyzed for 51 individual PCB congeners (48 peaks) and two chlorinated pesticides (p,p H -DDE and HCB). Choice of congeners for analysis was based on their potential toxicity and persistence in the environment (McFarland and Clarke, 1989) , their prevalence in commercial Aroclor mixtures (Schulz et al., 1989) , their presence in human serum or milk (Luotamo et al., 1985; Safe et al., 1985; Mes et al., 1987) , and their presence in New Bedford environmental samples, such as harbor sediments (Pruell et al., 1990) , seawater (Bergen et al., 1993) , and local fish and lobsters (Pruell et al., 1988) . The non-ortho -substituted congeners were not included as analytes because their concentrations were expected to be orders of magnitude lower than other congeners, and we did not expect to detect these congeners in cord serum. However, mono -ortho -substituted congeners, which contribute significantly to the total dioxin toxic equivalency (Van den Berg et al., 1998) , were measured. The sum of the congeners quantified for each Aroclor using our method indicated that the congeners that were chosen as target analytes represented about 77% of Aroclor 1016, 83% of Aroclor 1242, 99% of Aroclor 1248, 89% of Aroclor 1254, and 87% of Aroclor 1260. Individual PCB congeners were named according to the International Union for Pure and Applied Chemistry (IUPAC) nomenclature.
Sample Extraction
The extraction used procedures developed by the Centers for Disease Control and Prevention (Needham, undated) with modifications to conform to ultra -trace -level analyses. These modifications included additional and extensive cleaning of dry reagents and glassware (e.g., baking the silica gel at 4008C) and concentrating the extract volume to 100 l. Specifically, serum samples (mean size 3 1 g) were denatured with methanol and extracted with a 1:1 mixture of hexane and ethyl ether. The extracts were concentrated and eluted with hexane through an adsorption chromatographic column packed with deactivated silica gel. Before the extract volume was reduced to 100 l,``keeper'' solution (1% paraffin oil in hexane) was added to avoid the loss of more volatile target analytes (Burse et al., 1989) . The evaporation step was conducted at room temperature under a gentle stream of prepurified nitrogen.
Before extraction, each cord serum sample was spiked with the surrogate compounds, PCB congeners 103 and 112, to monitor the efficiency of the extraction procedure. Samples were processed in 51 batches typically of 14 ±16 cord serum samples each accompanied by the following quality control samples: a procedural blank, a field blank, two matrix spike samples, and, for most batches, an aliquot of pooled cord serum to assess interbatch laboratory coefficients of variation. SRM and interlaboratory comparison samples were included in select batches.
Instrumental Analysis
We analyzed the serum extracts by gas chromatography with electron capture detection (GC / ECD) using a Hewlett -Packard 5890 Series II GC with temperature and pressure programming capabilities and a split/splitless injector. We used a capillary column (DB5, 30 m, 0.25 mm, 0.25 m, from J&W Scientific, Folsom, CA) and the following instrumental conditions: injector at 3008C, detector at 3208C, initial oven temperature at 608C, hold for 1 min, heat to 1408C at 158 /min, then to 2308C at 18 /min, hold for 20 min, then heat to 2808C at 158/min with a final 10 -min hold. The carrier gas used was ultrahigh -purity (UHP) helium at a constant flow rate of 1.2 ml /min, and the make -up gas was UHP argon/methane (95 /5) at a flow rate of 60 ml /min.
Unexpectedly high concentrations of PCB congeners (primarily congeners 170 and 180) where there was possible contamination with phthalates, and congener 138 for which there was a coeluting contaminant consistently detected in procedural blanks, were checked by confirmatory analyses using a capillary column of different polarity, and, where results differed, the lower value was reported. Confirmatory analysis was done with a Hewlett -Packard 6890 GC with a Micro -ECD (GC /ECD) and a capillary column of different polarity (DBXLB, 30 m, 0.18 mm, 0.18 m, from J&W Scientific). The instrumental conditions were similar to the primary run, except the final column temperature was 2508C with a final 5 -min hold, and the make -up gas flow rate was 50 ml /min.
Sample Quantitation and Reporting
The GC data were quantified by the Hewlett -Packard software EnviroQuant GC. Congener 166 was added as an internal standard to all samples before instrumental analysis. Quantitation was based on the response factor of each individual PCB congener or pesticide relative to this internal standard, with use of pure standards of individual PCB congeners and the two chlorinated pesticides (p,p H -DDE and HCB). Peak area ratios of analyte to internal standard were compared with a linear calibration curve. PCB concentrations were reported as individual congeners and as the sum of all congeners assayed ( P PCB). Three pairs of congeners (77 /110, 157 / 201, 196 /203) co -eluted on the DB5 column and were reported as co -eluting. All final concentrations were reported after subtraction of the amount of analyte measured in the procedural blank associated with the analytic batch. Results were not adjusted for surrogate recoveries. Final concentrations were in units of nanograms of analyte per gram of serum.
Reagents Analytic standards of individual PCB congeners, p,p H -DDE, and HCB were obtained from AccuStandard (New Haven, CT) and Ultra Scientific (North Kingston, RI). The purity of all standards was at least 97%. Solvents were obtained from J.T. Baker Inc. (Phillipsburg, NJ). All solvents were of ultrahigh -purity grade.
Method Detection Limits Method detection limits (MDLs)
for the cord serum samples were determined on the basis of three times the standard deviation obtained from analysis of eight aliquots of pooled cord serum spiked with 0.07 ng of each target analyte, according to U.S. Environmental Protection Agency recommended methods (U.S. EPA, 1984) . We also estimated MDLs using three times the standard deviation of repeat measures of each target analyte in our 51 procedural blank specimens. Results of the two methods were comparable for most analytes.
Percentage Lipid Determination The lipid content of each serum sample was not measured because the sample volume was insufficient.
Method Validation Before initiating study sample analyses, we validated the serum extraction procedure by the extraction, in triplicate, of SRM (SRM 1589, National Institute of Standards and Technology, Aroclor 1260 in Human Serum). The mean SD percentage recovery for the SRM analyses was 100% 0.8%. Additional validation done before study sample analyses involved analysis of eight aliquots of pooled cord serum fortified with 0.2 ng of each target analyte/ gram of serum (Table 1) .
Quality Assurance and Quality Control Strict quality control and quality assurance procedures were followed in preparation for and during the study sample analyses. These procedures documented: GC calibration and response factor stability, MDLs, presence of interference or contamination, extraction efficiency, analytic accuracy, and analytic precision.
Instrument calibration was created with six concentrations of individual target analytes and verified every six samples or at least every 12 h of instrumental analysis. To verify the accuracy of our calibration standards, certified calibration check samples (CLB -1 Mixtures in Iso -octane of Individual Chlorinated Biphenyl Compounds, National Research Council, Canada) were analyzed with each newly prepared set of calibration standards and periodically during the study. The differences between the mean of measured concentrations and the certified values for all calibration congeners were within 5%.
Background contamination in each of the 51 analytical batches was determined by procedural blanks. The mean SD P PCB in the blanks was 0.32 0.24 ng /g. The mean procedural blank concentrations of p,p H -DDE and HCB were 0.005 0.01 and 0.006 0.003 ng/ g, respectively.
Analytic accuracy, precision, and extraction efficiency were evaluated by the analyses of SRM (SRM 1589, NIST Aroclor 1260 in Human Serum and CLB -1, National Research Council of Canada, Calibration Check Standards), one pair of matrix spike samples in each batch (aliquots of pooled cord serum spiked with 0.17 to 1.6 ng /g of each target analyte), and two surrogate compounds (PCB 103 and 112) added to each sample at 0.67 to 1.6 ng /g. Reproducibility was assessed in an analysis of 10 pairs of replicate (i.e., split) unspiked cord serum samples, with the analyst blind to the pairing and by analysis of 36 pairs (analyzed over 36 analytic batches) of matrix spike samples. Interbatch analytic precision was evaluated by analyzing unspiked aliquots of pooled cord serum included in 44 batches analyzed over 5 years of the study.
Interlaboratory Comparisons Serum reference pools and duplicate cord blood samples were split between our laboratory (Harvard School of Public Health) and the National Center for Environmental Health (NCEH, Centers for Disease Control and Prevention, Atlanta, GA) and analyzed before analysis of study samples was begun and then interspersed in the study analytic batches. In addition, in 1999 our laboratory participated in an international interlaboratory comparison of plasma PCB and pesticide analyses organized by the Institute for Quality Management in Medicine, University of Erlangen -Nuremberg, Germany. 
Data Analysis
Descriptive statistics were generated with SAS software (Statistical Analysis System, SAS Institute Inc., Cary, NC), and for certain laboratory summary measures, EXCEL (Microsoft Corp., Redmond, WA) was used.
The most prevalent PCB congeners were defined as those found at levels above the MDL for at least 50% of the infants. Values less than the MDL were assessed in two groups: (1) those for which a small but measurable quantity of analyte was found and (2) those for which no measurable quantity of analyte was detected, i.e., nondetectable values. Unless otherwise specified, all measurable quantities of analytes (including those that are less than the MDL) are reported. For the subset of values less than the MDL for which no measurable analyte was detected (or the procedural blank concentration exceeded the sample concentration), the sample concentration is reported as nondetectable (ND) and assigned a value of zero for purposes of calculating, for example, mean values. 153, 171, 183, 189, 199, 201, 203, 206, 209. f IUPAC congeners 101, 118, 138, 141, 151, 153, 170, 180, 187, 194, 195, 199, 209. g Aroclor 1260 in Human Serum, National Institute of Standards and Technology (NIST) SRM 1589. This SRM was extracted and analyzed 10 times from 1993 to 1995. Serum from goats exposed to each Aroclor. The unexposed sample is bovine serum. Each sample was analyzed in replicate by the Harvard laboratory and up to 11 times by the NCEH laboratory before initiation of study sample analyses. e Hagmar et al., 1998 . Geometric means are reported. f Rhainds et al., 1999 . Geometric means are reported. g Not available.
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Results
Analytic Sensitivity, Reproducibility and Accuracy Estimated percentage recovery for cord blood samples spiked with low concentrations of PCBs and pesticides ranged from 76% to 108% (Table 1) . Matrix spike percentage recovery for p,p H -DDE were high in batches for which, before spiking, the serum pool had high p,p H -DDE concentrations (e.g., !1 ng /g) relative to the amount of p,p H -DDE added from the spiking solution. The MDL for targeted individual PCB congeners ranged from 0.002 to 0.036 ng/ g of serum with most MDLs <0.01 ng /g of serum (Table 2 ). After subtraction of procedural blank values, p,p H -DDE was !MDL in 96% of samples, HCB was !MDL in 66% of samples, and 13 of the PCB congeners were measured at values !MDL in at least half of the samples.
In the blinded analysis of 10 split, unspiked samples, the within-sample (within run) coefficient of variation (CV) for P PCB was 7.5%; CVs for p,p H -DDE and HCB were 5% and 6%, respectively. The mean CVs of the 36 matrix spike pairs were 3% for P PCB, 5% for p,p H -DDE, and 7% for HCB. The interbatch CVs over the 5 years of analysis were 20% for P PCB, 20% for p,p H -DDE, and 39% for HCB with unspiked cord serum.
The relative percent difference (RPD) between our laboratory results and the certified value for SRMs was less than 5% in most comparisons (Table 3 ). In interlaboratory comparisons of analyses of unspiked cord serum samples, the RPD between our laboratory results and the NCEH (CDC) laboratory's were generally within 20% (Table 4) . Similar RPDs resulted from interlaboratory comparisons using serum reference pools with higher PCB concentrations (Table 4 ). The NCEH's cord serum results included a larger proportion of nondetectable values than did our laboratory's which, in part, may explain NCEH's lower mean concentrations for most analyses (Table 4 ). The RPDs between our laboratory results and reference values for two pools of plasma samples (one spiked with PCBs, p,p H -DDE and HCB at concentrations below 1.8 ng /ml and a second at concentrations above 1.8 ng /ml) in a 1999 international interlaboratory comparison were well within the tolerance range for certification and were generally within 15%.
Study Population
The majority (75%) of study infants were born to mothers residing in New Bedford, Massachusetts, the largest of the four towns adjacent to the contaminated site; the study mothers had lived in the area for an average of 20 years. The mean SD maternal age at the time of the study infant's birth was 26 5 years. The study infants were racially and ethnically diverse, with 26% of Portuguese descent and an additional 32% whose parent described them as non -white, Hispanic, or of other racial or ethnic groups. Most (62%) infants were born to multiparous mothers, approximately half of whom had breast -fed their previous infants.
PCB, p,p
H -DDE, and HCB levels in Cord Serum The concentrations of PCB congeners, p,p H -DDE, and HCB in the 751 New Bedford infants' cord serum samples are presented in Table 2 . The levels of p,p H -DDE in cord serum were generally higher than the levels of individual PCB congeners. The median P PCB was 0.38 ng/ g; the median p,p H -DDE and HCB cord serum concentrations were 0.29 and 0.023 ng /g serum, respectively. With a few exceptions, the serum PCB and p,p H -DDE concentrations among the study infants were generally lower than those in the few published population -based studies with congener-specific measures of PCBs in cord blood (Table 5) . Specifically, the New Bedford levels were similar to those in recently studied Canadian infants (Rhainds et al., 1999) (Table 5) . Also, for less -chlorinated PCB congeners (for example, congeners 99 and 118), study infants' samples had concentrations comparable to those in other populations, including groups at high risk for dietary PCB exposure (Koopman -Esseboom et al., 1994; Hagmar et al., 1998) (Table 5) . Despite low concentrations, maternal age was strongly correlated with both P PCB (Spearman r =0.43, p =0.0001) and p,p H -DDE (Spearman r= 0.46, p =0.0001) concentrations. There were moderate to strong correlations (Spearman r= 0.56 ±0.88) between P PCB and the 13 most prevalent PCB congeners (74, 99, 118, 138, 153, 167, 177, 180, 183, 187, 194, 196 / 203) . Correlations among commonly studied congeners Ð 118, 138, 153 and P PCB Ð ranged from 0.70 to 0.88.
Discussion
Cord blood currently offers the primary direct measure of prenatal exposure to the organochlorine contaminants studied. However, chemical analyses for the trace -level organochlorine content that is characteristic of most cord blood is technically difficult, costly, sensitive to background contamination or interfering compounds, and therefore prone to analytic error. Some of these limitations were apparent in our data. For all study analyses (e.g., infant serum samples, quality assurance and quality control samples, interlaboratory comparison samples), the final concentrations of PCBs and pesticides were reported after subtraction of the level of these analytes in procedural blanks analyzed with each batch. The procedural blank concentrations were very close to the sample concentrations. For example, the P PCB in procedural blanks averaged 0.32 ng /g compared with a final mean sample P PCB concentration (after subtraction of the procedural blank) of 0.54 ng /g of serum (Table 2) . Furthermore, despite sensitive methods, only 13 of the 51 PCB congeners assayed were above the MDL for at least half of the study infants.
Notwithstanding these limitations, the detection levels reported here (most MDLs <0.01 ng /g of serum) are lower than those generally reported for PCBs in serum. Part of this achievement is due to the use of extensively cleaned dry reagents and glassware, extraction of a relatively large sample (average 3 g) that was then concentrated to 100 l, and the use of an internal standard in sample quantitation. In addition, we were able to measure cord blood levels of the target compounds with minimal laboratory error (withinrun CVs of 7.5%, 5%, and 6% for P PCB, p,p H -DDE, and HCB, respectively). As expected, laboratory CVs over the entire 5 -year analysis period were greater (20% for P PCB, 20% for p,p H -DDE, and 39% for HCB). In general, precision of repeat analyses will decrease with increasing time between analyses because a variety of laboratory conditions, some of which are not controllable, change with time (Berthouex, 1993) . These within -run and between -run CVs were calculated with unspiked cord serum samples with trace -level concentrations of analytes, which is another source of decreased laboratory precision. That said, our 5 -year precision estimates for PCBs and p,p H -DDE are consistent with expectation for organochlorine analyses over a much shorter period (Burse et al., 1989) .
Our analytic method was robust to comparisons with certified SRM, with most RPDs less than 5% (Table 3 ). In analyses of split unspiked cord serum samples, our findings were generally concordant with duplicate analyses performed by a reference laboratory at the CDC's NCEH (Table 4) . Lastly, cord serum P PCB and p,p H -DDE levels varied with maternal age Ð a strong correlate of organochlorine levels in other populations (Laden et al., 1998) Ð which further validates results of our chemical analyses.
All of our data, including quality assurance, quality control, and interlaboratory comparison data include quantifiable values below the MDL. Although MDLs may vary depending on how they are estimated, data below the MDL, however defined, are expected to have greater variability and uncertainty than higher levels; this assumption is the basis for recommendations to censor such data. In the case of our cord serum analyses, a substantial proportion of our results would be censored at the MDL. However, in analyses of group data (as opposed to individual data points), censoring data at the detection limit discards useful information (Berthouex, 1993) . Where uncensored and censored datasets have been compared, the use of MDL cutoffs compromises the statistical power of analyses (e.g., for exposure ±disease relationships) and leads to biased exposure estimates (Kim et al., 1995) . This bias is a greater limitation than any increased variability of low values (Keith, 1994; Kim et al., 1995) . Thus, we retained measurable values below the MDL in our dataset. Results of our quality control and assurance analyses suggest that inclusion of values below the MDL did not compromise the precision or validity of our methods.
Having optimized our analytic methods, it is important to assess how our results compare with those of other studies. In general, the New Bedford area infants' cord serum PCB and DDT (or DDE) levels were lower than those reported in most other cohorts (Table 5) . However, comparing the New Bedford serum PCB and pesticide concentrations with those of earlier studies in which congener -specific analyses were not used is complicated by differences in analytic techniques. For example, although there are limited published data comparing the results of capillary and packed column analyses of the same samples, the sum of PCBs measured by capillary column congener -specific analyses has typically been estimated to account for between 50% and 90% of total PCBs measured by older techniques that relied on packed column analysis and Aroclor-based quantification methods (Burse et al., 1990 (Burse et al., , 1994 Johansen et al., 1994; Liem et al., 1996; Erickson, 1997) .
In one of the first population -based studies to assess cord blood organochlorines as a risk factor for developmental impairment in infancy and childhood, Jacobson et al. (1990) reported the mean SD of total cord serum PCB levels for 236 Michigan infants born in 1980± 1981 as 2.5 2.0 ng/ ml using packed column analyses. Assuming that the sum of PCB congeners determined by capillary column accounts for 50 ±90% of the total PCBs calculated by the packed column method (Burse et al., 1990 (Burse et al., , 1994 Johansen et al., 1994; Liem et al., 1996; Erickson, 1997) , these cord blood concentrations are roughly comparable to P PCB concentrations of between 1.3 and 2.3 ng/ ml cord serum, or approximately two -to fourfold greater than mean concentrations observed 12 ±18 years later in New Bedford. Consistent with this finding is the observation that U.S. population exposures to PCBs and DDT (or DDE) have generally declined since chemicals were banned from industrial use in the 1970s (Slorach and Vaz, 1985; Patterson et al., 1994; Noren et al., 1996) . In addition, most of these Michigan infants were selected because their mothers ate contaminated Great Lakes fish, whereas the New Bedford families were not selected on the basis of enhanced maternal consumption of contaminated fish. It is likely that differences in both true exposure (including dietary sources and those attributable to temporal declines in organochlorine contaminants) and analytic technique account for higher PCB concentrations among Michigan than among New Bedford infants.
In one of the earliest studies to use congener-specific analyses, Bush et al. (1984) measured PCBs, p,p H -DDE, and HCB in cord blood from infants born in 1977 who resided adjacent to PCB -contaminated waterways in upstate New York. The mean sum of PCBs (IUPAC 138, 153, and 180) was 42% lower among the New Bedford area infants compared to the upstate New York infants (Table 5 ). In analyses of U.S. population serum pools, some PCB congener concentrations declined by two -to sixfold between 1982 and 1989 (Patterson et al., 1994) . In this context, and in contrast to the Michigan findings described previously (Jacobson et al., 1990) , a 42% decline in PCBs in New Bedford area infants' cord blood compared with values for upstate New York infants born up to 21 years earlier is a surprisingly small change. However, it is possible that differences in analytic technique or matrix (e.g., the New York analyses used whole blood whereas our analyses used serum) may account for some of this unexpected similarity (Bush et al., 1984; Mes et al., 1992) .
The New Bedford cord serum concentrations were also generally lower than those in relatively contemporaneous populations of infants from industrialized European nations or heavy fish -eating populations (Janousek et al., 1994; Koopman -Esseboom et al., 1994; Hagmar et al., 1998; Winneke et al., 1998) (Table 5 ). For example, among 169 recently studied German infants (Winneke et al., 1998) , the mean sum of three PCBs (IUPAC 138, 153, and 180) in cord plasma was 0.55 ng/ ml compared with 0.19 ng/ g in New Bedford cord serum. Similarly, in cord plasma from Dutch infants, Koopman -Esseboom et al. (1994) measured the levels of four individual congeners (IUPAC 118, 138, 153, and 180) and reported an average sum of PCBs of 0.45 ng / g. In our study the sum of the same congeners was 0.25 ng / g. The Dutch are among western populations considered to be at high risk for PCB exposure (Patandin et al., 1997) . In contrast, the New Bedford infants' PCB levels were very similar to those reported among contemporaneous Canadian infants born to mothers without specific increased exposure risk (Rhainds et al., 1999) (Table 5 ). For example, the geometric mean concentrations of PCB congeners 118, 138, 153, and 180 in New Bedford cord serum were 0.04, 0.04, 0.06, and 0.03 ng /g compared with 0.02, 0.05, 0.05, and 0.03 ng/ ml, respectively, in Canadian infants (Rhainds et al., 1999) .
In an analysis of serum samples from 23 New Bedford area adults, Burse et al. (1994) noted a predominance of less -chlorinated PCB congeners even among individuals without occupational PCB exposure. This pattern was attributed to PCB exposure through consumption of local seafood (Burse et al., 1994) and is consistent with the predominant Aroclors used by New Bedford area industries (Weaver, 1984) and the characteristics of the harbor's contaminated sediments (Brown and Wagoner, 1990) . Similarly, some of the same congeners were relatively predominant in New Bedford cord serum compared with both earlier and contemporaneous studies (Table 5) . For example, despite lower P PCB values, the concentrations of congeners 99 and 118 in New Bedford cord serum were comparable to those in New York infants born in 1977 and Dutch infants born in the 1990s (Table 5) . Although the relative predominance of congeners 99 and 118 in the New Bedford cord serum samples is consistent with the PCB profile of the New Bedford harbor, analytic differences may, at least in part, explain this congener pattern. Specifically, we used a keeper solution to minimize loss of lesschlorinated congeners; this method is standard for some laboratories (including the NCEH laboratory), but it is not clear from published methods whether this approach was used in the other studies available for comparison.
In summary, despite the difficulties inherent in the analysis of organochlorines in cord serum, we were able to demonstrate that cord serum concentrations of PCBs and organochlorine pesticides (particularly p,p H -DDE) can be measured with sensitivity and reproducibility in a sample of 751 U.S. infants. Although these infants were identified for study because of maternal residence in towns adjacent to a PCB -contaminated harbor, cord serum PCB and pesticide concentrations in this population were (except for congeners 99 and 118) generally lower than those reported in most previous studies. Both differences in true exposure (including temporal declines in population organochlorine exposure) and differences in analytic methods probably account for the apparent lesser exposure among New Bedford infants. Although the effect of methodologic differences cannot be precisely quantified, it is likely that the New Bedford infants' cord serum P PCB levels reflect true exposures that are, on average, not more than 50% of what has been reported in U.S. cohorts born in the 1970s and 1980s, or among contemporaneous cohorts born in regions of the world with potential increased exposure risk, thereby underscoring the role of temporal, geographic, and dietary factors as sources of exposure variability.
However, for some PCB congeners predominant in the harbor and local seafood (99 and 118), New Bedford cord serum values are likely comparable to those reported in past decades and among populations at increased risk for PCB exposure. Because individual PCB congeners have differences in toxicity, and potentially counteracting biological effects, the characterization of both overall PCB levels and the pattern of individual PCB congener concentrations in New Bedford cord serum is important to our subsequent studies of the neurodevelopmental toxicities of prenatal PCB and pesticide exposures in this population. Indeed, careful exposure characterization is critical both to the assessment of potential adverse health effects of organochlorine exposure in early childhood and to the comparison of findings among different study populations.
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